WO2008039052A8 - Proceso para estabilización de famotidina - Google Patents
Proceso para estabilización de famotidina Download PDFInfo
- Publication number
- WO2008039052A8 WO2008039052A8 PCT/MX2007/000108 MX2007000108W WO2008039052A8 WO 2008039052 A8 WO2008039052 A8 WO 2008039052A8 MX 2007000108 W MX2007000108 W MX 2007000108W WO 2008039052 A8 WO2008039052 A8 WO 2008039052A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- famotidine
- composition
- wax
- present
- stabilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
La presente invención está relacionada con la industria farmacéutica, y más específicamente con la industria farmacéutica de la manufactura de productos a partir de la famotidina. La presente invención describe un método para estabilizar en pH alcalino a un inhibidor de receptores de H2 tal como lo es la Famotidina mediante un proceso de microencapsulación utilizando como materiales formadores de la película productos en cera o de naturaleza polimérica, tal como lo es la cera microcristalina, cera montánica, cera ozoquerita, chitosan o alginato de sodio. Las ventajas de la presente invención con respecto de los procedimientos del estado de la técnica es el de hacer posible con su aplicación de una composición de famotidina que resista más el medio de la composición en la que se encuentra y los efectos que pudiera tener la composición en el tracto digestivo. Sobre todo cuando esta sustancia se incluye en una composición conteniendo antiácido alcalino.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07834489A EP2085079A2 (en) | 2006-09-25 | 2007-09-24 | Process for stabilizing famotidine |
| BRPI0717425-0A BRPI0717425A2 (pt) | 2006-09-25 | 2007-09-24 | Processo para estabilização de famotidina |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA/A/2006/010972 | 2006-09-25 | ||
| MXPA06010972A MXPA06010972A (es) | 2006-09-25 | 2006-09-25 | Proceso para estabilizacion de famotidina. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO2008039052A2 WO2008039052A2 (es) | 2008-04-03 |
| WO2008039052A3 WO2008039052A3 (es) | 2008-06-19 |
| WO2008039052A8 true WO2008039052A8 (es) | 2009-05-07 |
Family
ID=39230698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/MX2007/000108 Ceased WO2008039052A2 (es) | 2006-09-25 | 2007-09-24 | Proceso para estabilización de famotidina |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2085079A2 (es) |
| AR (1) | AR062987A1 (es) |
| BR (1) | BRPI0717425A2 (es) |
| CL (1) | CL2007002760A1 (es) |
| CO (1) | CO6160290A2 (es) |
| CR (1) | CR10685A (es) |
| MX (1) | MXPA06010972A (es) |
| WO (1) | WO2008039052A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX351059B (es) * | 2012-08-17 | 2017-09-29 | Laboratorios Senosiain S A De C V Star | Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion. |
| WO2018083583A1 (en) * | 2016-11-01 | 2018-05-11 | Johnson & Johnson Consumer Inc. | Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid |
| AU2018343214B2 (en) * | 2017-09-29 | 2023-10-05 | Kenvue Brands Llc | Solid simethicone particles and dosage form thereof |
| CN112020350A (zh) | 2018-04-27 | 2020-12-01 | 强生消费者公司 | 液体口服药物剂型 |
| AU2019360443B2 (en) | 2018-10-18 | 2024-10-31 | Kenvue Brands Llc | Novel dosage form |
| US20220331294A1 (en) * | 2019-09-27 | 2022-10-20 | Johnson & Johnson Consumer Inc. | Gel-chewable dosage form |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1278167A (zh) * | 1997-10-27 | 2000-12-27 | 住友制药株式会社 | 酰胺衍生物 |
| US20050053655A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaceutical Industry Technology And Development Center | Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same |
-
2006
- 2006-09-25 MX MXPA06010972A patent/MXPA06010972A/es not_active Application Discontinuation
-
2007
- 2007-09-24 WO PCT/MX2007/000108 patent/WO2008039052A2/es not_active Ceased
- 2007-09-24 BR BRPI0717425-0A patent/BRPI0717425A2/pt not_active Application Discontinuation
- 2007-09-24 EP EP07834489A patent/EP2085079A2/en not_active Withdrawn
- 2007-09-25 CL CL200702760A patent/CL2007002760A1/es unknown
- 2007-09-25 AR ARP070104238A patent/AR062987A1/es not_active Application Discontinuation
-
2009
- 2009-03-24 CR CR10685A patent/CR10685A/es not_active Application Discontinuation
- 2009-03-25 CO CO09030530A patent/CO6160290A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO6160290A2 (es) | 2010-05-20 |
| WO2008039052A2 (es) | 2008-04-03 |
| MXPA06010972A (es) | 2009-04-17 |
| EP2085079A2 (en) | 2009-08-05 |
| WO2008039052A3 (es) | 2008-06-19 |
| AR062987A1 (es) | 2008-12-17 |
| CR10685A (es) | 2009-05-22 |
| CL2007002760A1 (es) | 2008-04-25 |
| BRPI0717425A2 (pt) | 2013-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008039052A8 (es) | Proceso para estabilización de famotidina | |
| WO2004043513A3 (en) | Surface dissolution and/or bulk erosion controlled release compositions and devices | |
| NZ594102A (en) | Sustained release of nutrients in vivo | |
| WO2008011126A3 (en) | Liquid compositions of calcium acetate | |
| WO2010039007A3 (ko) | 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법 | |
| EP2384739A3 (en) | Oral care product and methods of use and manufacture thereof | |
| HUE049048T2 (hu) | Proteinkoncentrátum keményítõtartalmú magokból: készítmény, elõállítási eljárás és alkalmazásai | |
| WO2009027944A3 (en) | Liquid acidic hard surface cleaning composition | |
| WO2009126649A3 (en) | Method of providing particles having biological-binding areas for biological applications | |
| WO2009126960A3 (en) | Multilayer fragrance encapsulation | |
| SI1896364T1 (sl) | Praĺ kasti apneni sestavek, postopek za proizvodnjo in uporaba le-tega | |
| WO2008020286A3 (en) | Pharmaceutical compositions of duloxetine | |
| ATE493893T1 (de) | Feste enymformulierungen und verfahren zu deren herstellung | |
| ATE472940T1 (de) | Komprimierter kaugummi und verfahren zu seiner herstellung | |
| WO2009007365A3 (fr) | Preparation de nanoparticules d'argent colloidale | |
| WO2008002691A3 (en) | A process for manufacturing a delivery system for active components as part of an edible composition | |
| TN2011000616A1 (en) | Feed block and method and apparatus for manufacturing of the feed block | |
| WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
| WO2008040322A3 (de) | Deformierbares substrat mit mikrostrukturierter oberfläche aus aufgebrachtem material sowie verfahren zur herstellung eines solchen substrates | |
| MX2012001973A (es) | Composicion de revestimiento de pelicula de compuestos de polvo solidos. | |
| WO2008019782A3 (de) | Dispersionen von nanoharnstoffen. enthaltend wirkstoffe | |
| EP1928431B8 (en) | Controlled release pharmaceutical composition containing carvedilol | |
| WO2009074732A8 (fr) | Bille de peinture marquante et son procede de fabrication | |
| WO2008019044A3 (en) | Amphiphilic grafts and co-networks and process for making same | |
| ATE500726T1 (de) | Tierstreu und herstellungsverfahren dafür |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: CR2009-010685 Country of ref document: CR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09030530 Country of ref document: CO Ref document number: 2007834489 Country of ref document: EP |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07834489 Country of ref document: EP Kind code of ref document: A2 |
|
| ENP | Entry into the national phase in: |
Ref document number: PI0717425 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090323 |